American Oncology Network (AON) and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform
29. Oktober 2024 08:00 ET
|
American Oncology Network
FORT MYERS, FL, Oct. 29, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX: AONC), one of the fastest-growing oncology networks in the United States, has partnered with Vantage Health...
Checkpoint Inhibitor Refractory Cancer (PD-L1 and PD-1) Market Research Report 2024-2030: Biomarker Testing Revolutionizes Treatment, Personalized Medicine and Immunotherapy Bolster Growth
23. Oktober 2024 06:33 ET
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Checkpoint Inhibitor Refractory Cancer Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application, End-User,...
The Institute for Value-Based Medicine® from The American Journal of Managed Care® hosts “Cardiac Care in a Value-Based World” event in Phoenix
21. Oktober 2024 09:00 ET
|
The American Journal of Managed Care
CRANBURY, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, is pleased to...
Genomics in Cancer Care Research Business Report 2023-2024 & 2030: Targeted Therapies and Genetic Testing Fuels Expansion, North America Leads, Asia-Pacific Emerging as a Key Growth Region
16. Oktober 2024 05:41 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Genomics in Cancer Care - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Genomics...
OncLive® and the Ruesch Center for the Cure of Gastrointestinal Cancers announce recipients of the 2024 Luminary Awards in GI Cancers
09. Oktober 2024 10:00 ET
|
OncLive®
CRANBURY, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) -- OncLive, the nation’s leading multimedia resource for oncology professionals, and the Ruesch Center for the Cure of Gastrointestinal (GI) Cancers at...
Prostate Cancer in the United States: Key Insights into Treatment Awareness & Satisfaction - Make Informed, Strategic Decisions, Identify Opportunities, and Understand Potential Challenges
26. September 2024 04:15 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Prostate Cancer in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
NTRK Fusion Gene Positive Advanced Solid Tumors Strategic Business Report 2024, with Coverage of Major Players such as Amoy Diagnostics, AnHeart Therapeutics, ARUP Laboratories, EntroGen and More
17. September 2024 08:00 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "NTRK Fusion Gene Positive Advanced Solid Tumors - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global...
Hologram Doctor-Patient Visits Launched by West Cancer Center
13. September 2024 09:20 ET
|
Proto
Berkeley, CA, Sept. 13, 2024 (GLOBE NEWSWIRE) -- West Cancer Center & Research Institute and Proto Inc. announced the first holographic doctor-patient visits at UC Berkeley’s forum on Global...
Hematologic Malignancies Testing Markets, 2023-2033: Growing Utilization of Next-Generation Sequencing and AI, Increasing Partnerships, Alliances, and Business Expansions among Key Players
13. August 2024 04:58 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Hematologic Malignancies Testing Market - A Global and Regional Analysis: Focus on Product, Platform, Disease, End User, and Region - Analysis and...
Renown Health pioneers HistoSonics Edison system delivering histotripsy for non-invasive liver tumor treatment
08. August 2024 16:18 ET
|
Renown Health
Reno, NEV., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Renown Health announced today that the first patients have received targeted liver tumor treatments through the Edison® System histotripsy technology,...